Cargando…

Tissue plasminogen activator versus heparin for locking dialysis catheters: A systematic review

BACKGROUND AND OBJECTIVES: Hemodialysis catheters are commonly used when renal replacement therapy is initiated. These catheters have significant complications. Among “locking” solutions used in an attempt to decrease these complications is recombinant tissue plasminogen activator (rt-PA). This syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Firwana, Belal M., Hasan, Rim, Ferwana, Mazen, Varon, Joseph, Stern, Aaron, Gidwani, Umesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507063/ https://www.ncbi.nlm.nih.gov/pubmed/23210006 http://dx.doi.org/10.4103/2231-0770.90913

Ejemplares similares

Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review
por: Firwana, Belal M., et al.
Publicado: (2012)

Undergraduate medical students’ perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria
por: Alahdab, Fares, et al.
Publicado: (2012)

A New Method for the Measurement of International Normalized Ratio in Hemodialysis Patients with Heparin-Locked Tunneled Dialysis Catheters
por: Seghers, Céline B., et al.
Publicado: (2020)

Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
por: Olthof, Evelyn D., et al.
Publicado: (2014)

Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
por: Huang, He-ming, et al.
Publicado: (2019)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial
por: Richtrova, Pavlina, et al.
Publicado: (2021)

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
por: Firwana, Belal, et al.
Publicado: (2012)

Clinical application of 4% sodium citrate and heparin in the locking of central venous catheters (excluding dialysis catheters) in intensive care unit patients: A pragmatic randomized controlled trial
por: Deng, Yuchun, et al.
Publicado: (2023)

Paradoxical Thromboembolic Ischemic Stroke Following Tissue Plasminogen Activator Instillation for Clogged Central Venous Dialysis Catheter
por: Nwosu, Ifeanyi, et al.
Publicado: (2021)

What should be the best dialysis catheter lock in critically ill patients?
por: Honore, Patrick M., et al.
Publicado: (2019)

Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial
por: Quenot, Jean-Pierre, et al.
Publicado: (2019)

Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleeding
por: Hryszko, Tomasz, et al.
Publicado: (2012)

Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients
por: Reidenberg, Bruce E., et al.
Publicado: (2017)

Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial
por: Wang, Rui, et al.
Publicado: (2015)

Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome
por: Mi, Yu-Hong, et al.
Publicado: (2013)

Routine Catheter Lock Solutions in Pediatric Cancer Care: A Pilot Randomized Controlled Trial of Heparin vs Saline
por: Ullman, Amanda J., et al.
Publicado: (2022)

Type II Heparin-Induced Thrombocytopenia: An Underrecognized Cause of Dialysis Catheter Dysfunction - A Case Report
por: Karki, Sailesh, et al.
Publicado: (2023)

Socio-demographic and Racial Differences in Acute Coronary Syndrome: Comparison between Saudi and South Asian Patients
por: Ferwana, Mazen
Publicado: (2013)

Use of Tissue Plasminogen Activator in Catheters Used for Extracorporeal Renal Replacement Therapy
por: Langston, C., et al.
Publicado: (2014)

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
por: Gulati, Vishal, et al.
Publicado: (2018)

A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients – the HEALTHY-CATH trial
por: Broom, Jennifer K, et al.
Publicado: (2012)

Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis
por: Al-Dorzi, Hasan M., et al.
Publicado: (2016)

Straight versus Coiled Peritoneal Dialysis Catheter: Conclusion is Not Straightforward
por: Prasad, Narayan
Publicado: (2022)

Low Concentration Trisodium Citrate as a Non-inferior Locking Agent for Non-tunneled Dialysis Catheters in the Asian Setting
por: Jayaprakash, Varadharajan, et al.
Publicado: (2019)

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients
por: Broom, Jennifer K, et al.
Publicado: (2009)

Catheter-related Infections and Microbiological Characteristics in Coiled Versus Straight Peritoneal Dialysis Catheters in Malaysia
por: Abdul Rashid, Anna M., et al.
Publicado: (2021)

Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial
por: Cia-Arriaza, Melania, et al.
Publicado: (2022)

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
por: Imbarrato, Gregory, et al.
Publicado: (2018)

Heparin versus normal saline for the care of peripheral intravenous catheters in children: A meta‐analysis
por: Zhang, Weiying, et al.
Publicado: (2023)

Nephrologists Hate the Dialysis Catheters: A Systemic Review of Dialysis Catheter Associated Infective Endocarditis
por: Janga, Kalyana C., et al.
Publicado: (2017)

Laparoscopy for continuous ambulatory peritoneal dialysis catheter placement and management of malfunctioning peritoneal dialysis catheter
por: Maheshwari, Pankaj N.
Publicado: (2019)

Prevalence of mental disorders among high school students in National Guard Housing, Riyadh, Saudi Arabia
por: Al-Sughayr, Abdulrhman M., et al.
Publicado: (2012)

Laparoscopic versus Open Peritoneal Dialysis Catheter Insertion: A Meta-Analysis
por: Hagen, Sander M., et al.
Publicado: (2013)

Maintenance of arterial catheters with heparin: should we continue?
por: Catorze, N, et al.
Publicado: (2011)

Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism
por: Patel, Darshan C., et al.
Publicado: (2019)

2117. Catheter-related Bacteremia in Hemodialysis Patients on Antibiotic Lock Therapy: Are Antibiotic Locks Ineffective?
por: Krishna, Amar, et al.
Publicado: (2018)

Laparoscopic Placement of Peritoneal Dialysis Catheter (Same Day Dialysis)
por: Al-Dohayan, Abdullah
Publicado: (1999)

Unexpected and striking effect of heparin-free dialysis on cytokine release
por: Rydzewska-Rosolowska, Alicja, et al.
Publicado: (2017)

Catheter Lock with Minocycline, EDTA and Ethanol for Salvaging of Central Venous Catheters in the Setting of Catheter-related Bloodstream Infections
por: Hachem, Ray Y, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lo24kdv6665jip2pfmri4648m5